LC-MS/MS analysis was performed on a Q Exactive mass spectrometer (Thermo Scientific) that was coupled to Easy nLC (Thermo Fisher Scientific) for 60/90 min
Unfortunately, when stopping weight loss medications cold turkey, weight regain is a common issue and this may affect your long-term progress
That means 84% of what you're taking is essentially wasted
Futhermore, 2025 results from the ATTAIN-MAINTAIN trial demonstrated orforgliprons ability to compete in the maintenance segment
About 19 percent of companies with 200 or more workers, and 43 percent of firms with 5,000 or more workers, covered GLP-1 drugs for weight loss in their largest health plan in 2025, according to research from the Peterson Center on Healthcare and the Kaiser Family Foundation (KFF)
[] However, in our study, it was uncertain how many patients in each group were on lipid-lowering agents, as this might affect the findings